Dr. Robert G. Penn, MD

Dr. Penn practices at Infectious Diseases Associates in Omaha, Nebraska.

Dr. Penn's NPI, 1013937374, was assigned on July 20, 2006. Dr. Penn graduated from UNMC in 1975. Dr. Penn holds Nebraska license 13129.

Dr. Penn's primary practice is Infectious Diseases Associates, at 8111 Dodge St, Omaha, NE 68114 in Douglas County. The practice phone is (402) 934-6504.

Dr. Penn's primary practice is Infectious Diseases Associates in Omaha, Nebraska. Dr. Penn is also affiliated with Methodist Hospital. The medical group on file is Infectious Diseases Associates, PC. Dmand AI also links Dr. Penn to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Penn practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Penn's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Penn is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Penn's licenses on file in 2 states: Nebraska and Iowa.

Dmand AI lists acute skin infection, bronchitis and pneumonia and respiratory infection among the conditions Dr. Penn treats.

CMS data shows 654 Medicare services from Dr. Penn across 5 procedure codes in 2024, for 95 Medicare patients. Medicare paid $41,112 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 95 Medicare patients who saw Dr. Penn in 2024. The largest group is 65 to 74, with 39 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 3.23, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Penn's median patient age at 53, with 61% women.

In 2024, Dr. Penn wrote 99 Medicare Part D claims for 30 patients. 94% of them were for generic drugs. CMS names the drug for 16 of them, across 1 drug with 11 or more claims each, at $217 in total drug cost. In 2023, CMS named 23 claims across 2 drugs.

Dr. Penn accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 16 papers to Dr. Penn in 2006. The most frequent topics are Drug Resistance, Microbial, beta-Lactamases and Microbial Sensitivity Tests. Dr. Penn has published most often in Nebr Med J.

CMS Open Payments shows 124 general payments to Dr. Penn from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 78% of the total. Astellas Pharma US Inc paid the most, $677.

Dmand AI lists 9 awards for Dr. Penn, most recently Meaning of Care Award (patient nominated) in 2015.

Dr. Penn graduated from UNMC in 1975.

Dr. Penn is in network with 17 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.